Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:24 PM
Ignite Modification Date:
2025-12-24 @ 5:24 PM
NCT ID:
NCT06728150
Eligibility Criteria:
Inclusion Criteria:
* Metastatic breast cancer with visceral, nodal or bone metastasis
* Human epidermal growth factor type2 (HER2-positive disease)
* Triple negative breast cancer (TNBC) with metastatic disease
* Oestrogen Receptor Positive disease (ER-positive disease) after second-line therapy and cyclin dependent kinase 4/6 inhibitors (CDK4/6 inhibitors), plus more than two sites of bone metastasis or visceral metastasis
* Diagnosis of metastatic disease in the last 3 months and free of symptoms or disease (with brain MRI confirmation) • Medicare Eligible
Exclusion Criteria:
* Symptomatic brain metastasis
* Inability to provide consent
* Inadequate organ function
* Pregnancy.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT06728150
Study Brief:
Protocol Section:
NCT06728150